
About Vitas Pharma Research Private Limited
Data last updated:
Vitas Pharma Research Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 07 June 2010.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2010PTC068813.
The company had an authorised share capital of ₹60 Lakh and a paid-up capital of ₹52.84 Lakh. It was led by directors Radha Rangarajan (Managing Director) and Rajinder Kumar.
Its last annual general meeting (AGM) was held on 31 October 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at Plot No.12 Aparna Orchids Madhapur, Hyderabad, Telangana, India – 500084.
As per the financials filed for FY 2020, the company reported a revenue of ₹1.07 Cr, a growth of 32% compared to the previous year. For the same year it recorded a net loss of ₹3.44 Cr (net margin -320.5%) and EBITDA of -₹3.44 Cr (EBITDA margin -320%). Revenue has grown at a compounded annual rate (CAGR) of 735% over three years and 13% over five years.
The company was associated with 1 brand: Vitas Pharma. As per MCA filings, the company had satisfied charges of ₹36.18 Lakh on record. The company has 4 deals on record (3 funding rounds, 1 acquisition), with disclosed funding of ₹3.2 Cr; the latest was in January 2015. Its 10 peer companies in the Pharma industry (Contract Research) are compared by revenue, 5 larger and 5 smaller; the largest is Mestastop Solutions Private Limited with revenue of ₹1.13 Cr.
The last known website on record is vitaspharma.com.
Company details
CIN history
Vitas Pharma Research has one previous CIN (Corporate Identification Number): U73100AP2010PTC068813. The current CIN is U73100TG2010PTC068813, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100TG2010PTC068813 | Current |
| U73100AP2010PTC068813 | Previous |
Contact details
Vitas Pharma Research Private Limited's registered office is in Hyderabad, Telangana. Its website is vitaspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No.12 Aparna Orchids Madhapur, Hyderabad, Telangana, India – 500084
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Vitas Pharma Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Vitas Pharma Research operates one associated brand: Vitas Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| An Indian preclinical-stage biopharma developing small molecule therapeutics for MDR bacterial infections. | vitaspharma.com |
Financials of Vitas Pharma Research Private Limited
FY 2020 filings availableVitas Pharma Research Private Limited reported revenue of ₹1.07 Cr (up 32% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 32% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.07 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.44 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.44 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -320% | ||||
| Net Profit Margin | -320.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vitas Pharma Research Private Limited, buy the company report.
Board of directors of Vitas Pharma Research Private Limited
Vitas Pharma Research has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajinder Kumar | Director | 07 Jun 2010 | 16 Years 5 Months | As last reported |
| Radha Rangarajan | Managing Director | 07 Jun 2010 | 16 Years 5 Months | As last reported |
Peer comparison
Vitas Pharma Research Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mestastop Solutions Private Limited | ₹1.13 Cr (FY 2025) | 743.0% | Bangalore, Karnataka, India | |||
| Pharmaforce Reports Private Limited | ₹1.12 Cr (FY 2019) | -15.0% | Pune, Maharashtra, India | |||
| Clinsearch Healthcare Solutions Private Limited | ₹1.1 Cr (FY 2024) | -11.0% | Thane, Maharashtra, India | |||
| Padm Laboratories Private Limited | ₹1.09 Cr (FY 2024) | -63.0% | Bangalore, Karnataka, India | |||
| Crom Clinical Research and Medical Tourism Private Limited | ₹1.08 Cr (FY 2024) | -67.0% | Panaji, Goa, India | |||
| Vitas Pharma Research Private Limitedthis company | ₹1.07 Cr (FY 2020) | -₹3.44 Cr | -320.5% | 32.0% | Hyderabad, Telangana, India | |
| Arkus Research Private Limited | ₹1.07 Cr (FY 2025) | -33.0% | South Bopal, Gujarat, India | |||
| Worldwide Clinical Trials India Private Limited | ₹1.07 Cr (FY 2025) | 6.0% | Mumbai, Maharashtra, India | |||
| Innovation Biologicals Private Limited | ₹1.06 Cr (FY 2025) | 10.0% | Pune, Maharashtra, India | |||
| Gharda Scientific Research Foundation | ₹1.05 Cr (FY 2025) | 80.0% | Mumbai, Maharashtra, India | |||
| Microvioma Private Limited | ₹1.03 Cr (FY 2025) | 15.0% | Bengaluru, Karnataka, India |
To see the full peer comparison of Vitas Pharma Research Private Limited, buy the company report.
Auditor
Vitas Pharma Research Private Limited is audited by G NATESAN & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G NATESAN & CO | FY 2020 | 002424S |
Shareholding
The shareholding of Vitas Pharma Research Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Vitas Pharma Research Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Dec 2012 | 10393945 | Biotechnology Industry Research Assistance Council | ₹36.18 Lakh | Satisfied |
To see the full charge records of Vitas Pharma Research Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Vitas Pharma Research Private Limited has 4 deals on record (3 funding rounds, 1 acquisition), with disclosed funding of ₹3.2 Cr; the latest was in January 2015.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2015 | Funding round | ₹3 Cr | Investors: 4 individuals |
| Mar 2014 | Funding round | ₹9 Lakh | Investors: an individual |
| Mar 2013 | Funding round | ₹11 Lakh | Investors: an individual |
| Dec 2012 | Acquisition | ₹31 Lakh | Buyer: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Vitas Pharma Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vitas Pharma Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Vitas Pharma Research Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Vitas Pharma Research Private Limited has 3 board changes on record since 2010: 2 appointments and 1 cessation. The latest: Radha Rangarajan ceased to be Director on 01 Oct 2011.
Frequently asked questions
Vitas Pharma Research has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Vitas Pharma Research was a private limited company based in Hyderabad, Telangana, India. The company worked in pharma contract r and d, within the pharma industry. It was incorporated on 07 June 2010 and is registered under CIN U73100TG2010PTC068813. The company has been struck off by the Registrar of Companies and is no longer operational.
Vitas Pharma Research had 2 directors:
- Radha Rangarajan - Managing Director
- Rajinder Kumar - Director
The CIN (Corporate Identification Number) of Vitas Pharma Research is U73100TG2010PTC068813. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Vitas Pharma Research is at Plot No.12 Aparna Orchids Madhapur, Hyderabad, Telangana, India – 500084.
Vitas Pharma Research was incorporated on 07 June 2010. It is registered with the Registrar of Companies, Hyderabad.
Vitas Pharma Research can be reached through the website vitaspharma.com. Its registered office is in Hyderabad, Telangana, India.
The latest financial statements of Vitas Pharma Research on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 October 2020. Year-wise statements from 2015 are in the company report.
Vitas Pharma Research operated in the pharma industry, in the pharma contract r and d segment. It worked in this industry before it was struck off.
Vitas Pharma Research has 4 deals on record (3 funding rounds, 1 acquisition), with disclosed funding of ₹3.2 Cr; the latest was in January 2015.
The peers of Vitas Pharma Research by revenue are Mestastop Solutions Private Limited, Pharmaforce Reports Private Limited, Clinsearch Healthcare Solutions Private Limited, Padm Laboratories Private Limited, Crom Clinical Research and Medical Tourism Private Limited and 5 more, all in the Pharma industry (Contract Research).

